Vilon – 20MG

Scientific Overview of Vilon

Vilon, also referred to as Lyslglutamic Acid, has been investigated as a peptide bioregulator with potential roles in gene regulation, immune support, and cellular maintenance. Research suggests it may interact with chromatin structures, influence signaling pathways, and contribute to processes associated with aging and stress response. Scientists have explored its relevance in tumor biology, cardiovascular studies, and longevity research, positioning it as a peptide of broad scientific interest.

Alternative Names: Lysylglutamate, Normophthal, Lyslglutamic Acid

Studies and Research Data

Investigations in Cellular Aging

Studies have suggested that Vilon may influence cellular longevity and tissue regeneration. In experimental models, it appeared to support muscle endurance, reduce age-related cellular decline, and protect against premature aging in thymic and splenic tissues exposed to radiation. Additional research indicates a potential role in stabilizing organ function and sustaining cellular performance under stress.

Vilon Research on Tumor Biology

In animal studies, Vilon was associated with a lower frequency of tumor formation and slower progression of malignant changes. Observations in bladder cancer models indicated fewer alterations in mucosal tissues and reduced hyperplasia. These findings suggest the peptide may influence pathways linked to tumor development, although mechanisms remain under investigation.

Vilon Studies on Immune Dynamics

Experimental findings indicate that Vilon may support immune coordination by influencing chromatin activity and interleukin signaling. Reports suggest it may enhance T-cell activity and differentiation, with observed increases in markers such as CD5. Such effects point toward a role in supporting balanced immune function and reactivating silenced genetic processes.

Observations in Vascular and Organ Systems

Research involving cardiovascular and renal models indicates that Vilon may play a role in regulating vascular permeability and maintaining balance in hemostatic processes. In studies combining Vilon with other peptides, shifts in cardiac gene expression were observed, while kidney studies suggested possible benefits in moderating fibrosis-related signaling molecules.

Conclusion

Current scientific literature positions Vilon as a peptide of interest in areas spanning cellular aging, tumor biology, immune system regulation, and vascular balance. Its potential mechanisms appear to involve chromatin modulation and signaling regulation, but research remains exploratory and no definitive outcomes have been established.

References

1. Kuznik BI, et al. Effect of Vilon on immunity and coagulation in patients with diabetes. Adv Gerontol. 2007;20(2):106-15. PMID: 18306698.
2. Pliss GB, et al. Inhibitory effect of peptide Vilon on the development of induced rat urinary bladder tumors. Bull Exp Biol Med. 2001 Jun;131(6):558-60. doi: 10.1023/a:1012354603132. PMID: 11586406.
3. Kniaz'kin IV, et al. Effect of Vilon on thymus and spleen in radiation-induced aging. Adv Gerontol. 2002;9:105-9. PMID: 12096431.
4. Lezhava T, et al. Vilon-induced reactivation of chromatin in cultured lymphocytes from old people. Biogerontology. 2004;5(2):73-9. PMID: 15105581.
5. Anisimov VN, Khavinson VKh. Peptide bioregulators for cancer prevention: results of 35 years. Vopr Onkol. 2009;55(3):291-304. PMID: 19670728.
6. Sevostianova NN, et al. Immunomodulating effects of Vilon and its analogue in thymus cells. Bull Exp Biol Med. 2013 Feb;154(4):562-5.
7. Barykina OP, et al. Combined effect of Vilon and cyclophosphane on tumor transplants and lymphoid tissue explants. Adv Gerontol. 2003;12:128-31. PMID: 14743610.
8. Kniaz'kin IV, et al. Functional morphology of spleen organotypic cultures under Vilon. Adv Gerontol. 2002;9:110-5. PMID: 12096432.
9. Gavrisheva NA, et al. Effect of peptide Vilon on TGF-beta and microvessel permeability in renal failure. Bull Exp Biol Med. 2005 Jan;139(1):24-6. doi: 10.1007/s10517-005-0202-9. PMID: 16142267.
10. Lezhava T, et al. Anti-aging peptide bioregulators induce reactivation of chromatin. Georgian Med News. 2006 Apr;(133):111-5. PMID: 16705247.
11. Khavinson VKh, Anisimov VN. A synthetic dipeptide Vilon (L-Lys-L-Glu) inhibits growth of spontaneous tumors and increases life span of mice. Dokl Biol Sci. 2000 May-Jun;372:261-3. PMID: 10944717.
12. Anisimov VN, et al. Effect of thymus and pineal factors on life span and tumor development. Mech Ageing Dev. 1989 Sep;49(3):245-57. PMID: 2682058.

Disclaimer:
The products mentioned are intended solely for laboratory research and in-vitro experimentation. They are not approved for human or animal use of any kind. All details provided are for educational purposes only. By purchasing from this site, you agree to comply with our Terms and Conditions.